Clinical trial

Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial

Recruiting now · Not applicable · 1 countries · Registry ID NCT04852198

Recruiting nowNot applicableInterventional

What this study is about

The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionBariatric Surgery Candidate, Obesity, Obesity, Morbid

Full registry criteria

Inclusion Criteria: * body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee) * a positive evaluation by our BMDT Exclusion Criteria: * Presence of H. Pylori, resistant to eradication therapy * chronic diarrhoea * history of previous bariatric or extensive abdominal surgery

Treatments and study arms

OAGB

Procedure

Simplified gastric bypass procedure

RYGB

Procedure

Roux-en-Y gastric bypass. Standard procedure in the Netherlands

Primary outcomes

Percentage excess BMI loss at 2 years (%EBMIL)2 years

Percentage excess BMI loss after 2 years of follow-up

Study locations

2 locations were listed when this page was built. The first 40 are shown.

Flevoziekenhuis🇳🇱 Almere Stad, Netherlands
Floris Bruinsma, MDContact
Christel Boons, PhDContact
OLVG🇳🇱 Amsterdam, Netherlands
Phillip Dijkhorst, MDContact
Robin DebiContact